Login

Financial Snapshot

Revenue
TTM
$0.00
Gross Margin
Last 4 Quarters
N/A
Net Income
TTM
-$3.259M
Current Assets
2023 Q3
$749.5K
Current Liabilities
2023 Q3
$9.661M
Current Ratio
2023 Q3
7.76%
Total Assets
2023 Q3
$789.3K
Total Liabilities
2023 Q3
$11.68M
Book Value
2023 Q3
-10.89M
Cash
Last 4 Quarters
N/A
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$91.74K

Stock Price

Loading...
Market Cap: $9.47 Thousand

About Innoveren Scientific, Inc.

Innoveren Scientific, Inc. is a hybrid-biopharmaceutical company. The company is headquartered in Cincinnati, Ohio. The company went IPO on 2014-12-19. The firm is focused on advancing new technologies in areas of unmet need across multiple indications for improving patient lives. The firm is also focused on investing in and fosters technologies that are supported by a scientific foundation.

Industry: Surgical & Medical Instruments & Apparatus Peers: ACTAVIA LIFE SCIENCES, INC. Allena Pharmaceuticals, Inc. GlobeStar Therapeutics Corp GridAI Technologies Corp Endonovo Therapeutics Inc PREMIER BIOMEDICAL INC

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support